Targeting the thioredoxin system as a novel strategy against B‐cell acute lymphoblastic leukemia

B‐cell precursor acute lymphoblastic leukemia (BCP‐ALL) is a genetically heterogeneous blood cancer characterized by abnormal expansion of immature B cells. Although intensive chemotherapy provides high cure rates in a majority of patients, subtypes harboring certain genetic lesions, such as MLL rea...

Descripción completa

Detalles Bibliográficos
Autores principales: Fidyt, Klaudyna, Pastorczak, Agata, Goral, Agnieszka, Szczygiel, Kacper, Fendler, Wojciech, Muchowicz, Angelika, Bartlomiejczyk, Marcin Adam, Madzio, Joanna, Cyran, Julia, Graczyk‐Jarzynka, Agnieszka, Jansen, Eugene, Patkowska, Elzbieta, Lech‐Maranda, Ewa, Pal, Deepali, Blair, Helen, Burdzinska, Anna, Pedzisz, Piotr, Glodkowska‐Mrowka, Eliza, Demkow, Urszula, Gawle‐Krawczyk, Karolina, Matysiak, Michal, Winiarska, Magdalena, Juszczynski, Przemyslaw, Mlynarski, Wojciech, Heidenreich, Olaf, Golab, Jakub, Firczuk, Malgorzata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487705/
https://www.ncbi.nlm.nih.gov/pubmed/30861284
http://dx.doi.org/10.1002/1878-0261.12476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487705/
https://www.ncbi.nlm.nih.gov/pubmed/30861284
http://dx.doi.org/10.1002/1878-0261.12476

Ejemplares similares